A Phase III, Multicenter, Double-Blind, Randomized Trial to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Subjects With Type 2 Diabetes Mellitus For Whom Metformin is Inappropriate due to Intolerance or Contraindication
Read time: 1 mins
Last updated:21st Aug 2013
1. to assess the A1C-lowering efficacy of MK-3102 compared with glimepiride. 2. To assess the safety and tolerability of MK-3102.
|Study start date||2013-08-21|